Business Description
Skye Bioscience is a San Diego-based drug development company working to create new treatments for obesity and related metabolic conditions. Its most advanced program centers on nimacimab, an antibody designed to dial down the activity of a specific receptor linked to how the body manages weight and metabolism. The company operates under a name it adopted in early 2021, having previously been known as Emerald Bioscience.
